Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Int J Obes (Lond). 2021 Jan;45(1):109-121. doi: 10.1038/s41366-020-0616-5. Epub 2020 Jun 4.
Obesity, a global challenge, is a complex disorder linked to various diseases. Different kinds of treatments are currently used to treat or control this pandemic. Despite their positive effects on controlling obesity, they still have limitations and side effects including digestive problems, difficulties of daily infusion of some drugs, surgical complications, and weight regain. All these issues cause these conventional methods not to have desirable efficacy. In this regard, brown adipose tissue (BAT) transplantation as a new investigational treatment is proposed, which has beneficial effects with no documented side effect in studies up to now.
This systematic review protocol was registered in the International Prospective Register of Systematic Reviews (Registration Number: CRD42018110045). The systematical search was conducted on Web of Science, Scopus, PubMed, Embase, and ProQuest databases. The quality assessments in the included studies and data gathering were conducted independently by two authors. The main variables were anthropometric indices including body weight, levels of leptin, IGF-1, glucagon, adiponectin, fasting blood glucose, and UCP-1.
Following the search in mentioned databases, ten articles were entered into this systematic review. In most studies, weight gain and white adipocyte size were reduced in the BAT transplant group. It seems that the transplantation leads to the regeneration of healthy adipose tissue by activating the endogenous BAT.
Since BAT transplantation is one of the possible future treatments of obesity, many studies are conducted to evaluate the outcomes and related procedures precisely, so it can finally step into clinical application.
肥胖是一个全球性的挑战,是一种与多种疾病相关的复杂疾病。目前有多种治疗方法用于治疗或控制这种大流行。尽管它们对控制肥胖有积极的影响,但它们仍然存在局限性和副作用,包括消化问题、某些药物日常输注困难、手术并发症和体重反弹。所有这些问题导致这些常规方法没有理想的疗效。在这方面,棕色脂肪组织(BAT)移植作为一种新的研究性治疗方法被提出,迄今为止的研究没有记录到其有任何副作用。
本系统评价方案已在国际前瞻性系统评价登记处(注册号:CRD42018110045)注册。系统检索了 Web of Science、Scopus、PubMed、Embase 和 ProQuest 数据库。对纳入研究的质量评估和数据收集由两名作者独立进行。主要变量包括体重、瘦素、IGF-1、胰高血糖素、脂联素、空腹血糖和 UCP-1 水平等人体测量指标。
在上述数据库中进行搜索后,有 10 篇文章纳入本系统评价。在大多数研究中,BAT 移植组的体重增加和白色脂肪细胞大小减少。这似乎表明移植通过激活内源性 BAT 导致健康脂肪组织的再生。
由于 BAT 移植是肥胖症的未来治疗方法之一,因此进行了许多研究来精确评估其结果和相关程序,以便最终能够进入临床应用。